Tianyu Qu

455 total citations · 1 hit paper
16 papers, 305 citations indexed

About

Tianyu Qu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tianyu Qu has authored 16 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tianyu Qu's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (4 papers). Tianyu Qu is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (4 papers). Tianyu Qu collaborates with scholars based in China and United Kingdom. Tianyu Qu's co-authors include Renhua Guo, Erbao Zhang, Dandan Yin, Xiyi Lu, Xuezhi He, Chen Zhang, Yanan Cui, Liang Han, Qingqing Zhu and Chongguo Zhang and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Tianyu Qu

16 papers receiving 305 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer

2025 17 citations Xiyi Lu, Chang Zhang et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Tianyu Qu

Since Specialization

Citations

This map shows the geographic impact of Tianyu Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyu Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyu Qu more than expected).

Fields of papers citing papers by Tianyu Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyu Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyu Qu. The network helps show where Tianyu Qu may publish in the future.

Co-authorship network of co-authors of Tianyu Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyu Qu. A scholar is included among the top collaborators of Tianyu Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyu Qu. Tianyu Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer 2025 ·Cancer Research ·Tianyu Qu, (unknown), (unknown), (unknown), Dandan Yin, (unknown), (unknown), (unknown), Erbao Zhang	2
2	NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer breakdown → 2025 ·Molecular Cancer ·(unknown), Xiyi Lu, Chang Zhang, Tianyu Qu, Wei Li, Jun Su, Renhua Guo, Dandan Yin, Pingping Wu, Liang Han, Erbao Zhang	17
3	8q24 derived ZNF252P promotes tumorigenesis by driving phase separation to activate c-Myc mediated feedback loop 2025 ·Nature Communications ·Tianyu Qu, Chang Zhang, Xiyi Lu, (unknown), Xuezhi He, (unknown), Liang Han, Dandan Yin, Erbao Zhang	4
4	Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension 2024 ·Respiratory Research ·Chun Zhang, (unknown), (unknown), Tianyu Qu, Yingying Liu, (unknown), (unknown), Qun Wang, (unknown), Ruifeng Zhang	3
5	Methyltransferase-Like 3–Driven N6-Methyladenosine Modification of Recombination Signal Binding Protein for Immunoglobulin Kappa J Region Promotes Vascular Remodeling in Pulmonary Hypertension 2024 ·American Journal Of Pathology ·(unknown), (unknown), Tianyu Qu, (unknown), (unknown), Zhixuan Chen, (unknown), Pingsheng Chen, Ruifeng Zhang	3
6	LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer 2023 ·Cell Death and Disease ·(unknown), Tianyu Qu, Dandan Yin, Yanan Cui, Chen Zhang, Erbao Zhang, Renhua Guo	65
7	Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis 2023 ·Thoracic Cancer ·(unknown), Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Renhua Guo	2
8	MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer 2022 ·Cancer Research ·Qingqing Zhu, Chongguo Zhang, Tianyu Qu, Xiyi Lu, Xuezhi He, (unknown), Dandan Yin, Liang Han, Renhua Guo, Erbao Zhang	65
9	Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer 2022 ·Oncogene ·Xiyi Lu, Jing Wang, Wei Wang, Chenfei Lu, Tianyu Qu, Xuezhi He, Xinyin Liu, Renhua Guo, Erbao Zhang	37
10	High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis 2021 ·Frontiers in Oncology ·Qianqian Wang, (unknown), Tianyu Qu, (unknown), Lingxiang Wu, Kening Li, Ziyu Wang, Mengyan Zhu, Bin Huang, Wei Wu, Min Wu, Rong Ding, Zhihong Zhang, (unknown), Qianghu Wang, Xinyi Xia, Pengping Li, Zhi Zhang, Renhua Guo	16
11	Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting 2021 ·BMC Cancer ·Qianqian Wang, Wen Gao, Fangyan Gao, Shidai Jin, Tianyu Qu, Fan Lin, Chen Zhang, Jingya Zhang, Zhihong Zhang, Liang Chen, Renhua Guo	9
12	RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma 2021 ·Journal of Cellular and Molecular Medicine ·Fangyan Gao, Qianqian Wang, Chang Zhang, Chen Zhang, Tianyu Qu, Jingya Zhang, Ji‐Fu Wei, Renhua Guo	21
13	Research on Path Planning Algorithm Based on Dimensionality Reduction Method and Improved RRT 2020 ·Global Oceans 2020: Singapore – U.S. Gulf Coast ·(unknown), Hua Yang, (unknown), Tianyu Qu, (unknown), Dalei Song	4
14	Down-regulated MAC30 expression inhibits breast cancer cell invasion and EMT by suppressing Wnt/β-catenin and PI3K/Akt signaling pathways. 2019 ·PubMed ·Tianyu Qu, Yi Zhao, (unknown), (unknown), (unknown), (unknown), Li Sun, (unknown)	24
15	Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/β-catenin pathway in vitro 2017 ·Stem Cell Research ·Jianqun Wu, Song Liu, (unknown), Tianyu Qu, Su Fu, Zhao Wang, Jianguo Yang, Dan Jin, Bin Yu	32
16	Study on atom transfer radical polymerization initiated by p-nitrophenyl initiator and synthesis of amino end-functionalized polymers thereof 2010 ·Macromolecular Research ·Tianyu Qu, Wenqian Cai, Zhifeng Fu, Yan Shi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact